Gilead’s 4-drug combination pill Quad for HIV achieves endpoint
Earlier on Monday, Gilead Sciences Inc. announced that a late-stage study for a 4-drug combination pill “Quad,” intended to treat
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine